ENDRA Life Sciences (NDRA) EBT Growth (3y) (2019 - 2026)
ENDRA Life Sciences (NDRA) EBT Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 10.40% |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | -1.90% |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 13.42% |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 2.67% |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | -7.07% |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 14.73% |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 70.10% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 3.19% |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 9.13% |
| 10 | ENDRA Life Sciences | 5.44 Mn | 5.08 Mn | - | 23.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.62% |
| Dec 31, 2025 | 1.24% |
| Sep 30, 2025 | 22.59% |
| Jun 30, 2025 | 30.11% |
| Mar 31, 2025 | 28.69% |
| Dec 31, 2024 | -10.15% |
| Sep 30, 2024 | 3.97% |
| Jun 30, 2024 | 11.34% |
| Mar 31, 2024 | -6.95% |
| Dec 31, 2023 | 13.44% |
| Sep 30, 2023 | 1.64% |
| Jun 30, 2023 | 4.04% |
| Mar 31, 2023 | 3.97% |
| Dec 31, 2022 | 11.89% |
| Sep 30, 2022 | -0.26% |
| Jun 30, 2022 | -15.44% |
| Mar 31, 2022 | -1.31% |
| Dec 31, 2021 | -9.49% |
| Sep 30, 2021 | 1.23% |
| Jun 30, 2021 | -20.10% |